The European Centre for Disease Prevention and Control (ECDC) has published an updated response plan to tackle the threat of drug-resistant gonorrhoea in Europe.
Gonorrhoea is the second most notified sexually transmitted infection in EU and EEA countries after Chlamydia. The overall trend between 2008-2017, among 20 of the 28 EU/EEA countries which consistently report on this, showed an increase in the number of notified gonorrhoea cases. Over the past decades, Neisseria gonorrhoeae has developed antimicrobial resistance (AMR) to several antimicrobial classes.
The first ECDC response plan was published in 2012. The 2019 update aims to further support EU member states in developing and implementing national strategies and interventions to control the threat of multidrug-resistant and extensively drug-resistant gonorrhoea, by outlining the suggested public health response to this threat.
Preventing the emergence and spread of AMR in N. gonorrhoeae is just one aspect of gonorrhoea control as part of comprehensive management strategies which include appropriate treatment, diagnostics and testing algorithms, test of cure, notification and treatment of partners, enhanced focus on risk groups and STI prevention measures, which includes advocating increased condom use.
Source: ECDC, 7 October 2019